Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	json	split
In addition, integrin ligation leads to nuclear translocation of the p50 and p65 subunits of the NF - kappa B transcription factor, to activation of a reporter gene driven by a promoter containing NF - kappa B sites, and to increased levels of mRNAs for immediate - early genes, including the cytokine interleukin ( IL) - 1 beta.	integrin,13,21,Gene/Protein	p50,69,72,Gene/Protein	p65 subunits,77,89,Gene/Protein	NF - kappa B transcription factor,97,130,Gene/Protein	reporter gene,151,164,Gene/Protein	promoter,177,185,Gene/Protein	NF - kappa B sites,197,215,Gene/Protein	mRNAs,244,249,Gene/Protein	immediate - early genes,254,277,Gene/Protein	"[{""token"": ""integrin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B transcription factor"", ""start_span"": 97, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B sites"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""mRNAs"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early genes"", ""start_span"": 254, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
Kinase C mediates its effects via phosphorylation of serum response factor ( SRF) which interacts with the serum response element ( SRE); cAMP and calcium mediate their effects via phosphorylation of CREB ( cAMP regulatory element binding protein) presumably by activation of a protein kinase A or calmodulin - regulated kinase.	Kinase C,0,8,Gene/Protein	serum response factor,53,74,Gene/Protein	SRF,77,80,Gene/Protein	serum response element,107,129,Gene/Protein	SRE,132,135,Gene/Protein	CREB,200,204,Gene/Protein	cAMP regulatory element binding protein,207,246,Gene/Protein	protein kinase A,278,294,Gene/Protein	calmodulin - regulated kinase,298,327,Gene/Protein	"[{""token"": ""Kinase C"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""serum response element"", ""start_span"": 107, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""SRE"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""cAMP regulatory element binding protein"", ""start_span"": 207, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 278, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin - regulated kinase"", ""start_span"": 298, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
The interaction of the transcription factors, activator protein - 1 ( AP - 1), nuclear factor kappa B ( NF kappa B), and cAMP - responsive element binding protein ( CREB) with DNA and glucocorticoid receptors ( GR) was analyzed in human peripheral blood mononuclear cells by gel mobility shift assays.	transcription factors,23,44,Gene/Protein	activator protein - 1,46,67,Gene/Protein	AP - 1,70,76,Gene/Protein	nuclear factor kappa B,79,101,Gene/Protein	NF kappa B,104,114,Gene/Protein	cAMP - responsive element binding protein,121,162,Gene/Protein	CREB,165,169,Gene/Protein	glucocorticoid receptors,184,208,Gene/Protein	GR,211,213,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 79, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - responsive element binding protein"", ""start_span"": 121, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptors"", ""start_span"": 184, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 211, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Replacement of the NF - kappa B elements in the HIV - 1 LTR by a DNA fragment derived from the 5 ' - flanking region of IFN - stimulated gene 15 ( ISG15), containing the IFN - stimulated response element, partially restored Tat - mediated activation of LTR in T cells as well as in monocytes.	NF - kappa B elements,19,40,Gene/Protein	HIV - 1 LTR,48,59,Gene/Protein	DNA fragment,65,77,Gene/Protein	5 ' - flanking region,95,116,Gene/Protein	IFN - stimulated gene 15,120,144,Gene/Protein	ISG15,147,152,Gene/Protein	IFN - stimulated response element,170,203,Gene/Protein	Tat,224,227,Gene/Protein	LTR,253,256,Gene/Protein	"[{""token"": ""NF - kappa B elements"", ""start_span"": 19, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""DNA fragment"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 95, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated gene 15"", ""start_span"": 120, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""ISG15"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated response element"", ""start_span"": 170, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
The germline promoters ( Ko) located upstream of the J region gene segments of the kappa locus also contain an octamer motif ( containing a single base pair mutation and referred to as the variant octamer) which has been shown previously to bind Oct - 1 and Oct - 2 transcription factors in vitro.	germline promoters,4,22,Gene/Protein	Ko,25,27,Gene/Protein	J region gene segments,53,75,Gene/Protein	kappa locus,83,94,Gene/Protein	octamer motif,111,124,Gene/Protein	base pair mutation,147,165,Gene/Protein	Oct - 1,246,253,Gene/Protein	Oct - 2,258,265,Gene/Protein	transcription factors,266,287,Gene/Protein	"[{""token"": ""germline promoters"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Ko"", ""start_span"": 25, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""J region gene segments"", ""start_span"": 53, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""kappa locus"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 111, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""base pair mutation"", ""start_span"": 147, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 266, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Although IL - 2 - induced phosphorylation of IL - 2R beta, JAK1, and STAT5 all required the presence of JAK3, IL - 4 - mediated phosphorylation of JAK1, STAT6, and insulin receptor substrates 1 and 2 did not.	IL - 2,9,15,Gene/Protein	IL - 2R beta,45,57,Gene/Protein	JAK1,59,63,Gene/Protein	STAT5,69,74,Gene/Protein	JAK3,104,108,Gene/Protein	IL - 4,110,116,Gene/Protein	JAK1,147,151,Gene/Protein	STAT6,153,158,Gene/Protein	insulin receptor,164,180,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor"", ""start_span"": 164, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Analysis of the accumulation of mRNA - encoding members of the AP - 1 transcription factor family demonstrated that c - fos and junB are also expressed upon stimulation of NK and T cells with IL - 2, but not IL - 12, whereas expression of c - jun and junD is not modified by either cytokine.	mRNA - encoding members,32,55,Gene/Protein	AP - 1 transcription factor family,63,97,Gene/Protein	c - fos,116,123,Gene/Protein	junB,128,132,Gene/Protein	IL - 2,192,198,Gene/Protein	IL - 12,208,215,Gene/Protein	c - jun,239,246,Gene/Protein	junD,251,255,Gene/Protein	cytokine,282,290,Gene/Protein	"[{""token"": ""mRNA - encoding members"", ""start_span"": 32, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor family"", ""start_span"": 63, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""junD"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 282, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	train
Newly translated STAT1 binds in equilibrium fashion to STAT2 and STAT3, but we show that STAT2 and STAT3 exist in separate heterocomplexes with STAT1, consistent with a model in which STAT1 contains a common binding site for other STAT proteins.	STAT1,17,22,Gene/Protein	STAT2,55,60,Gene/Protein	STAT3,65,70,Gene/Protein	STAT2,89,94,Gene/Protein	STAT3,99,104,Gene/Protein	heterocomplexes,123,138,Gene/Protein	STAT1,144,149,Gene/Protein	STAT1,184,189,Gene/Protein	STAT proteins,231,244,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""heterocomplexes"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 231, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Selective phosphatase inhibitors for protein phosphatase 1 ( PP1) and 2A ( PP2A) that do not inhibit calcineurin, such as okadaic acid and calyculin A, also inhibited NFAT activation with IC50s of 87 nM and 4 nM, respectively, suggesting that okadaic acid and related inhibitors may block NFAT activation through the inhibition of PP1, instead of PP2A.	protein phosphatase 1,37,58,Gene/Protein	PP1,61,64,Gene/Protein	2A,70,72,Gene/Protein	PP2A,75,79,Gene/Protein	calcineurin,101,112,Gene/Protein	NFAT,167,171,Gene/Protein	NFAT,289,293,Gene/Protein	PP1,331,334,Gene/Protein	PP2A,347,351,Gene/Protein	"[{""token"": ""protein phosphatase 1"", ""start_span"": 37, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""2A"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 289, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 347, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	train
Pretreatment of monocytes with IFN - beta or IFN - gamma, but not IL - 1, IL - 2, macrophage colony - stimulating factor, granulocyte / macrophage colony - stimulating factor, IL - 6, or transforming growth factor beta suppressed activation of STAT6 by IL - 4.	IFN - beta,31,41,Gene/Protein	IFN - gamma,45,56,Gene/Protein	IL - 1,66,72,Gene/Protein	IL - 2,74,80,Gene/Protein	macrophage colony - stimulating factor,82,120,Gene/Protein	granulocyte / macrophage colony - stimulating factor,122,174,Gene/Protein	IL - 6,176,182,Gene/Protein	STAT6,244,249,Gene/Protein	IL - 4,253,259,Gene/Protein	"[{""token"": ""IFN - beta"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor"", ""start_span"": 82, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony - stimulating factor"", ""start_span"": 122, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Domain E, considered as the putative hormone binding domain ( HBD) of the human mineralocorticoid receptor ( hMR) was expressed in Escherichia coli as a fusion protein with either maltose binding protein ( MBP) or glutathione S - transferase ( GST).	Domain E,0,8,Gene/Protein	putative hormone binding domain,28,59,Gene/Protein	HBD,62,65,Gene/Protein	human mineralocorticoid receptor,74,106,Gene/Protein	hMR,109,112,Gene/Protein	maltose binding protein,180,203,Gene/Protein	MBP,206,209,Gene/Protein	glutathione S - transferase,214,241,Gene/Protein	GST,244,247,Gene/Protein	"[{""token"": ""Domain E"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""putative hormone binding domain"", ""start_span"": 28, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""human mineralocorticoid receptor"", ""start_span"": 74, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""maltose binding protein"", ""start_span"": 180, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""glutathione S - transferase"", ""start_span"": 214, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""GST"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
The influence on interleukin ( IL) - 2, IL - 4 and interferon ( IFN) - gamma production; IL - 2 receptor ( IL - 2R) alpha -, beta -, and gamma - chain; and the signaling pathway molecules Janus kinase ( Jak) 1, Jak3, signal transducers and activators of transcription ( Stat) 1, Stat3, and Stat5 should be investigated.	IL - 4,40,46,Gene/Protein	beta,125,129,Gene/Protein	gamma - chain,137,150,Gene/Protein	signaling pathway molecules,160,187,Gene/Protein	Janus kinase,188,200,Gene/Protein	Jak3,211,215,Gene/Protein	activators of transcription,240,267,Gene/Protein	Stat3,279,284,Gene/Protein	Stat5,290,295,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""gamma - chain"", ""start_span"": 137, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""signaling pathway molecules"", ""start_span"": 160, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 240, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 290, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
An electrophoretic mobility shift assay employing AP - 1 and NF - kappaB consensus oligonucleotides was used to demonstrate that AP - 1 - binding activity increased, while constitutive NF - kappaB - binding activity was not enhanced, following 2 h of CD19 cross - linking in 1E8 cells. Supershift experiments revealed that JunD and c - Fos proteins mediated anti - CD19 induced AP - 1 - binding activity in 1E8 cells.	AP - 1,50,56,Gene/Protein	NF - kappaB,61,72,Gene/Protein	AP - 1,129,135,Gene/Protein	NF - kappaB,185,196,Gene/Protein	CD19,251,255,Gene/Protein	JunD,323,327,Gene/Protein	c - Fos proteins,332,348,Gene/Protein	CD19,365,369,Gene/Protein	AP - 1,378,384,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 323, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos proteins"", ""start_span"": 332, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 365, ""end_span"": 369, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 378, ""end_span"": 384, ""type"": ""Gene/Protein""}]"	train
In the case of IgE class switching, IL - 4 activates the IgE germline promoter by inducing the interaction of the transcription factor STAT6 ( IL - 4STAT) with a responsive DNA element in the proximal region of the promoter.	IgE,15,18,Gene/Protein	IL - 4,36,42,Gene/Protein	IgE germline promoter,57,78,Gene/Protein	transcription factor,114,134,Gene/Protein	STAT6,135,140,Gene/Protein	IL - 4STAT,143,153,Gene/Protein	responsive DNA element,162,184,Gene/Protein	proximal region,192,207,Gene/Protein	promoter,215,223,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IgE germline promoter"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4STAT"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""responsive DNA element"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""proximal region"", ""start_span"": 192, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Immunological studies in human immunodeficiency virus ( HIV) - positive patients suggest that the disease progression is accompanied by a defective production of type 1 cytokines ( interleukin - 2 ( IL - 2) and IL - 12], an increased production of type 2 cytokines ( IL - 4, IL - 6, and IL - 10), and an increased production of IgE.	1 cytokines,167,178,Gene/Protein	interleukin - 2,181,196,Gene/Protein	IL - 2,199,205,Gene/Protein	IL - 12,211,218,Gene/Protein	type 2 cytokines,248,264,Gene/Protein	IL - 4,267,273,Gene/Protein	IL - 6,275,281,Gene/Protein	IL - 10,287,294,Gene/Protein	IgE,328,331,Gene/Protein	"[{""token"": ""1 cytokines"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""type 2 cytokines"", ""start_span"": 248, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 267, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 275, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 287, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
T - cell receptor ( TCR) / CD3 engagement results in the activation of nuclear factor of activated T cells ( NFAT), activator protein - 1 ( AP - 1), and nuclear factor kappaB ( NFkappaB), whereas the CD28 responsive complex ( CD28RC) is activated in response to the CD28 signal.	T - cell receptor,0,17,Gene/Protein	NFAT,109,113,Gene/Protein	activator protein - 1,116,137,Gene/Protein	AP - 1,140,146,Gene/Protein	nuclear factor kappaB,153,174,Gene/Protein	NFkappaB,177,185,Gene/Protein	CD28 responsive complex,200,223,Gene/Protein	CD28RC,226,232,Gene/Protein	CD28,266,270,Gene/Protein	"[{""token"": ""T - cell receptor"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""CD28 responsive complex"", ""start_span"": 200, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Cytokine - stimulated cell surface expression of vascular cell adhesion molecule - 1 ( VCAM - 1, CD106) and E - selectin ( ELAM - 1, CD62E), but not of intercellular adhesion molecule - 1 ( ICAM - 1, CD54), was time - and dose - dependently inhibited by TCP succinate but not by TCP or TCP acetate.	vascular cell adhesion molecule - 1,49,84,Gene/Protein	VCAM - 1,87,95,Gene/Protein	CD106,97,102,Gene/Protein	E - selectin,108,120,Gene/Protein	ELAM - 1,123,131,Gene/Protein	CD62E,133,138,Gene/Protein	intercellular adhesion molecule - 1,152,187,Gene/Protein	ICAM - 1,190,198,Gene/Protein	CD54,200,204,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 49, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""ELAM - 1"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 152, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD54"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Examination of the basal factors interacting with the 21 bp repeat elements through electrophoretic mobility shift ( EMS) analyses has demonstrated the formation of DNA - protein complexes common to each of the 21 bp repeats ( C1 - C3) as well as three DNA - protein complexes specific to the promoter proximal ( pp) repeat ( U1 ( U1A / U1B) and U2; 1 - 4).	basal factors,19,32,Gene/Protein	21 bp repeat elements,54,75,Gene/Protein	DNA - protein complexes,165,188,Gene/Protein	21 bp repeats,211,224,Gene/Protein	C1 - C3,227,234,Gene/Protein	DNA - protein complexes,253,276,Gene/Protein	U1,326,328,Gene/Protein	U1A / U1B,331,340,Gene/Protein	U2,346,348,Gene/Protein	"[{""token"": ""basal factors"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeat elements"", ""start_span"": 54, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 165, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeats"", ""start_span"": 211, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 227, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 253, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 326, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 331, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 346, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
Putative cis - acting control elements present within a 300 - bp core promoter included two ets sites, an Sp1 site, tandem E - box domains, two GATA - associated sites ( CACCC), an AP - 2 binding site, and a GATA element at - 24.	cis - acting control elements,9,38,Gene/Protein	300 - bp core promoter,56,78,Gene/Protein	ets sites,92,101,Gene/Protein	Sp1 site,106,114,Gene/Protein	E - box domains,123,138,Gene/Protein	GATA - associated sites,144,167,Gene/Protein	AP - 2 binding site,181,200,Gene/Protein	GATA element,208,220,Gene/Protein	- 24,224,228,Gene/Protein	"[{""token"": ""cis - acting control elements"", ""start_span"": 9, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""300 - bp core promoter"", ""start_span"": 56, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""ets sites"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""E - box domains"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GATA - associated sites"", ""start_span"": 144, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 binding site"", ""start_span"": 181, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""GATA element"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""- 24"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
In order to investigate the nature of the A6H mAb costimulus at the transcriptional level we have examined induction of the transcription factors OCT - 1, AP - 1 and NF - kappa B which are known to be transcriptional regulators of several cytokine and cytokine receptor genes, including the IL - 2 and IL - 2R genes.	A6H mAb,42,49,Gene/Protein	transcription factors,124,145,Gene/Protein	OCT - 1,146,153,Gene/Protein	AP - 1,155,161,Gene/Protein	NF - kappa B,166,178,Gene/Protein	transcriptional regulators,201,227,Gene/Protein	cytokine,239,247,Gene/Protein	cytokine,252,260,Gene/Protein	IL - 2 and IL - 2R genes,291,315,Gene/Protein	"[{""token"": ""A6H mAb"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 201, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 239, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 and IL - 2R genes"", ""start_span"": 291, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
A motif presenting a strong similarity to an initiator was detected, as well as putative binding sites for Sp1, GATA - 2, LyF - 1, ets - 1, AP1, and MZF1 transcription factors, and two GAS motifs.	putative binding sites,80,102,Gene/Protein	Sp1,107,110,Gene/Protein	GATA - 2,112,120,Gene/Protein	LyF - 1,122,129,Gene/Protein	ets - 1,131,138,Gene/Protein	AP1,140,143,Gene/Protein	MZF1,149,153,Gene/Protein	transcription factors,154,175,Gene/Protein	GAS motifs,185,195,Gene/Protein	"[{""token"": ""putative binding sites"", ""start_span"": 80, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""LyF - 1"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ets - 1"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""MZF1"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 154, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GAS motifs"", ""start_span"": 185, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Using Tax mutants that fail to activate either ATF - or NF - kappaB - dependent promoters and different 5 ' truncation mutants of the E2F - 1 promoter, we show that the Tax - dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F - 1 promoter.	Tax,6,9,Gene/Protein	ATF,47,50,Gene/Protein	NF - kappaB - dependent promoters,56,89,Gene/Protein	5 ' truncation mutants,104,126,Gene/Protein	E2F - 1 promoter,134,150,Gene/Protein	Tax,169,172,Gene/Protein	E2F1 gene,216,225,Gene/Protein	ATF binding site,258,274,Gene/Protein	E2F - 1 promoter,290,306,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - dependent promoters"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""5 ' truncation mutants"", ""start_span"": 104, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 promoter"", ""start_span"": 134, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""E2F1 gene"", ""start_span"": 216, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""ATF binding site"", ""start_span"": 258, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 promoter"", ""start_span"": 290, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
In the transient - transfection assay, ICP0, but not ICP4, activated the HIV - 1 long terminal repeat promoter region and the effect of ICP0 was greatly enhanced in the presence of the NF - kappa B binding proteins, suggesting that induction of the HIV - 1 provirus involves cooperation between the HSV - 1 - activated cellular factor, NF - kappa B, and the virus - encoded transactivator, ICP0.	ICP0,39,43,Gene/Protein	ICP4,53,57,Gene/Protein	HIV - 1 long terminal repeat promoter region,73,117,Gene/Protein	ICP0,136,140,Gene/Protein	NF - kappa B binding proteins,185,214,Gene/Protein	HSV - 1 - activated cellular factor,299,334,Gene/Protein	NF - kappa B,336,348,Gene/Protein	virus - encoded transactivator,358,388,Gene/Protein	ICP0,390,394,Gene/Protein	"[{""token"": ""ICP0"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ICP4"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat promoter region"", ""start_span"": 73, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""ICP0"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding proteins"", ""start_span"": 185, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""HSV - 1 - activated cellular factor"", ""start_span"": 299, ""end_span"": 334, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 336, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""virus - encoded transactivator"", ""start_span"": 358, ""end_span"": 388, ""type"": ""Gene/Protein""}, {""token"": ""ICP0"", ""start_span"": 390, ""end_span"": 394, ""type"": ""Gene/Protein""}]"	train
Similarly, in transfection experiments in which the selective kappa B binding sites were used to drive the expression of a chloramphenicol acetyltransferase reporter construct, the p65 - and p50 - selected motifs were activated only in the presence of p65 and p50 / 65 ( a chimeric protein with the p50 DNA binding domain and p65 activation domain) expression vectors, respectively, and neither demonstrated a significant response to stimuli that induce NF - kappa B activity.	selective kappa B binding sites,52,83,Gene/Protein	chloramphenicol acetyltransferase reporter construct,123,175,Gene/Protein	p65 - and p50 - selected motifs,181,212,Gene/Protein	p65,252,255,Gene/Protein	p50 / 65,260,268,Gene/Protein	chimeric protein,273,289,Gene/Protein	p50 DNA binding domain,299,321,Gene/Protein	p65 activation domain,326,347,Gene/Protein	NF - kappa B,454,466,Gene/Protein	"[{""token"": ""selective kappa B binding sites"", ""start_span"": 52, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter construct"", ""start_span"": 123, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""p65 - and p50 - selected motifs"", ""start_span"": 181, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""p50 / 65"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""chimeric protein"", ""start_span"": 273, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding domain"", ""start_span"": 299, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""p65 activation domain"", ""start_span"": 326, ""end_span"": 347, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 454, ""end_span"": 466, ""type"": ""Gene/Protein""}]"	train
A number of genes known to be induced following T cell activation and associated with cell growth were increased in the transfectants, including c - fos, c - myc, c - myb, HLA - DR, lck, NF - kappa B, interleukin - 2 and interleukin - 2 receptor alpha ( IL - 2R alpha).	c - fos,145,152,Gene/Protein	c - myc,154,161,Gene/Protein	c - myb,163,170,Gene/Protein	HLA - DR,172,180,Gene/Protein	lck,182,185,Gene/Protein	NF - kappa B,187,199,Gene/Protein	interleukin - 2,201,216,Gene/Protein	interleukin - 2 receptor alpha,221,251,Gene/Protein	IL - 2R alpha,254,267,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""lck"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 receptor alpha"", ""start_span"": 221, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 254, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
A small 95 - bp fragment of the TCR alpha control region that contains the TCF - 1 alpha binding site juxtaposed between a cAMP - response element ( the CRE or T alpha 1 motif) and the binding site for a distinct lymphoid - specific protein ( TCF - 2 alpha) behaved as a potent T - cell - specific enhancer in vivo.	TCR alpha control region,32,56,Gene/Protein	TCF - 1 alpha binding site,75,101,Gene/Protein	cAMP - response element,123,146,Gene/Protein	CRE,153,156,Gene/Protein	T alpha 1 motif,160,175,Gene/Protein	binding site,185,197,Gene/Protein	lymphoid - specific protein,213,240,Gene/Protein	TCF - 2 alpha,243,256,Gene/Protein	T - cell - specific enhancer,278,306,Gene/Protein	"[{""token"": ""TCR alpha control region"", ""start_span"": 32, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha binding site"", ""start_span"": 75, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - response element"", ""start_span"": 123, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""T alpha 1 motif"", ""start_span"": 160, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 185, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid - specific protein"", ""start_span"": 213, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 2 alpha"", ""start_span"": 243, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific enhancer"", ""start_span"": 278, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL - 2 in human T cells, and specifically required a COOH - terminal region of IL - 2R beta ( Ser386 - Val525), while STAT5 recruitment was not correlated to activation of IL - 2R gamma or JAK3.	STAT5,10,15,Gene/Protein	STAT transcription factor,48,73,Gene/Protein	IL - 2,82,88,Gene/Protein	COOH - terminal region,135,157,Gene/Protein	IL - 2R beta,161,173,Gene/Protein	Ser386 - Val525,176,191,Gene/Protein	STAT5,200,205,Gene/Protein	IL - 2R gamma,254,267,Gene/Protein	JAK3,271,275,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""STAT transcription factor"", ""start_span"": 48, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal region"", ""start_span"": 135, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Ser386 - Val525"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 254, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Recently it has become clear that these cytokines activate a number of important intracellular signaling molecules, including the Janus kinases JAK1 and JAK3 and members of the transcription factor family of signal transducers and activators of transcription ( STATs).	cytokines,40,49,Gene/Protein	intracellular signaling molecules,81,114,Gene/Protein	Janus kinases,130,143,Gene/Protein	JAK1,144,148,Gene/Protein	JAK3,153,157,Gene/Protein	transcription factor family,177,204,Gene/Protein	signal transducers,208,226,Gene/Protein	activators of transcription,231,258,Gene/Protein	STATs,261,266,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""intracellular signaling molecules"", ""start_span"": 81, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor family"", ""start_span"": 177, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers"", ""start_span"": 208, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 231, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 261, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	valid
However, the components of the NF - kappaB complexes were different in monocytes and B cells, because p50 is part of the NF - kappaB complex induced by CD40 triggering in both monocytes and B cells, whereas p65 was only induced in B cells. In contrast, although the Janus kinase 3 tyrosine kinase was associated with CD40 molecules in both monocytes and resting B cells, Janus kinase 3 phosphorylation induction was observed only in CD40 - activated monocytes, with subsequent induction of STAT5a DNA binding activity in the nucleus.	NF - kappaB complexes,31,52,Gene/Protein	p50,102,105,Gene/Protein	NF - kappaB complex,121,140,Gene/Protein	CD40,152,156,Gene/Protein	p65,207,210,Gene/Protein	Janus kinase 3 tyrosine kinase,266,296,Gene/Protein	CD40,317,321,Gene/Protein	Janus kinase 3,371,385,Gene/Protein	STAT5a,490,496,Gene/Protein	"[{""token"": ""NF - kappaB complexes"", ""start_span"": 31, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB complex"", ""start_span"": 121, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3 tyrosine kinase"", ""start_span"": 266, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 317, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 371, ""end_span"": 385, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 490, ""end_span"": 496, ""type"": ""Gene/Protein""}]"	valid
Single - cell reverse transcriptase - polymerase chain reaction ( RT - PCR) analysis was applied to this culture system to investigate gene expression of diverse receptors, markers of differentiation, and transcription factors ( EKLF, GATA - 1, GATA - 2, p45 NF - E2, PU. 1, and SCL / Tal1) at discrete stages of erythropoietic development.	reverse transcriptase,14,35,Gene/Protein	receptors,162,171,Gene/Protein	markers of differentiation,173,199,Gene/Protein	transcription factors,205,226,Gene/Protein	EKLF,229,233,Gene/Protein	GATA - 1,235,243,Gene/Protein	GATA - 2,245,253,Gene/Protein	p45 NF - E2,255,266,Gene/Protein	SCL / Tal1,279,289,Gene/Protein	"[{""token"": ""reverse transcriptase"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""receptors"", ""start_span"": 162, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""markers of differentiation"", ""start_span"": 173, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 205, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 245, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""p45 NF - E2"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""SCL / Tal1"", ""start_span"": 279, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	valid
Because STAT6 activation plays an essential role in IL - 4 / IL - 13 - induced gene expression, the ability of IFN - beta and IFN - gamma to inhibit STAT6 activity provides an explanation for how IFNs can suppress IL - 4 / IL - 13 - inducible gene expression.	STAT6,8,13,Gene/Protein	IL - 4,52,58,Gene/Protein	IL - 13,61,68,Gene/Protein	IFN - beta,111,121,Gene/Protein	IFN - gamma,126,137,Gene/Protein	STAT6,149,154,Gene/Protein	IFNs,196,200,Gene/Protein	IL - 4,214,220,Gene/Protein	IL - 13,223,230,Gene/Protein	"[{""token"": ""STAT6"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 214, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	valid
The 3 ' - CAGGTG E - box could bind USF proteins, the ubiquitous repressor ZEB, or the basic helix - loop - helix proteins E2A and HEB, and we showed that a competition between ZEB and E2A / HEB proteins is involved in the silencer activity.	3 ' - CAGGTG E - box,4,24,Gene/Protein	USF proteins,36,48,Gene/Protein	ubiquitous repressor,54,74,Gene/Protein	ZEB,75,78,Gene/Protein	basic helix - loop - helix proteins,87,122,Gene/Protein	E2A,123,126,Gene/Protein	HEB,131,134,Gene/Protein	ZEB,177,180,Gene/Protein	E2A / HEB proteins,185,203,Gene/Protein	"[{""token"": ""3 ' - CAGGTG E - box"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""USF proteins"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous repressor"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""basic helix - loop - helix proteins"", ""start_span"": 87, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""HEB"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""E2A / HEB proteins"", ""start_span"": 185, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	valid
Transfection of EL - 4 cells with the IL - 4 promoter - reporter constructs carrying mutated P - like elements showed that four P - like elements, CLE0, P, P2 and P4, but not P3, were required for optimal activation of the IL - 4 promoter.	IL - 4 promoter - reporter constructs,38,75,Gene/Protein	mutated P - like elements,85,110,Gene/Protein	P - like elements,128,145,Gene/Protein	CLE0,147,151,Gene/Protein	P,153,154,Gene/Protein	P2,156,158,Gene/Protein	P4,163,165,Gene/Protein	P3,175,177,Gene/Protein	IL - 4 promoter,223,238,Gene/Protein	"[{""token"": ""IL - 4 promoter - reporter constructs"", ""start_span"": 38, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""mutated P - like elements"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""P - like elements"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""P"", ""start_span"": 153, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""P2"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""P4"", ""start_span"": 163, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""P3"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 promoter"", ""start_span"": 223, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	valid
We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular and transmembrane domains of the erythropoietin receptor and of the intracellular domain of IL - 4Ralpha induces Janus kinase 1 ( Jak1) activation, STAT6 activation, and Cepsilon germline transcripts in human B cell line BJAB.	chimeric surface receptors,50,76,Gene/Protein	extracellular and transmembrane domains,95,134,Gene/Protein	erythropoietin receptor,142,165,Gene/Protein	intracellular domain,177,197,Gene/Protein	IL - 4Ralpha,201,213,Gene/Protein	Janus kinase 1,222,236,Gene/Protein	Jak1,239,243,Gene/Protein	STAT6,257,262,Gene/Protein	Cepsilon germline transcripts,279,308,Gene/Protein	"[{""token"": ""chimeric surface receptors"", ""start_span"": 50, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""extracellular and transmembrane domains"", ""start_span"": 95, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin receptor"", ""start_span"": 142, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 177, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4Ralpha"", ""start_span"": 201, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 1"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""Cepsilon germline transcripts"", ""start_span"": 279, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	valid
Analyzed DNA sequences included delta and beta 5 ' flanking regions extending from approximately - 500 to + 50bp ( promoter regions), truncated delta and beta 5 ' flanking regions extending from approximately - 250 to + 50 bp, and chimeric promoter constructions, which consisted of a distal delta or beta fragment fused to a proximal beta or delta sequence.	DNA sequences,9,22,Gene/Protein	delta and beta 5 ' flanking regions,32,67,Gene/Protein	- 500 to + 50bp,97,112,Gene/Protein	promoter regions,115,131,Gene/Protein	beta 5 ' flanking regions,154,179,Gene/Protein	- 250 to + 50 bp,209,225,Gene/Protein	chimeric promoter constructions,231,262,Gene/Protein	delta or beta fragment,292,314,Gene/Protein	proximal beta or delta sequence,326,357,Gene/Protein	"[{""token"": ""DNA sequences"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""delta and beta 5 ' flanking regions"", ""start_span"": 32, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""- 500 to + 50bp"", ""start_span"": 97, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 115, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""beta 5 ' flanking regions"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""- 250 to + 50 bp"", ""start_span"": 209, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""chimeric promoter constructions"", ""start_span"": 231, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""delta or beta fragment"", ""start_span"": 292, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""proximal beta or delta sequence"", ""start_span"": 326, ""end_span"": 357, ""type"": ""Gene/Protein""}]"	valid
The PILOT protein has a calculated M ( r) of 42. 6 kDa and contains three zinc fingers of the C2H2 - type at the carboxyl - terminus which are highly homologous to the zinc finger regions of the transcription factors EGR1, EGR2, and pAT 133.	PILOT,4,9,Gene/Protein	zinc fingers,74,86,Gene/Protein	C2H2 - type,94,105,Gene/Protein	carboxyl - terminus,113,132,Gene/Protein	zinc finger regions,168,187,Gene/Protein	transcription factors,195,216,Gene/Protein	EGR1,217,221,Gene/Protein	EGR2,223,227,Gene/Protein	pAT 133,233,240,Gene/Protein	"[{""token"": ""PILOT"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""C2H2 - type"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminus"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger regions"", ""start_span"": 168, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""EGR1"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""EGR2"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""pAT 133"", ""start_span"": 233, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	valid
Results indicated that ( i) constitutive c - fos transcript levels are significantly higher in patients subsequently responding to IFN - alpha therapy ( p < 0. 01) and positively correlated with the proportion of lymphocytes ( r = 0. 6895, p < 0. 01) and negatively with the proportion of immature cells ( r = - 0. 568, p < 0. 01) contained in the pbmc preparations tested, ( ii) constitutive mRNA levels of the hybrid bcr / abl, c - myc and p53 are positively correlated with each other, but failed to relate to disease parameters, and ( iii) acute and chronic in vivo exposure to IFN - alpha is accompanied by upregulation of c - fos and downregulation of c - myc mRNA levels in responder patients.	c - fos transcript,41,59,Gene/Protein	IFN - alpha,131,142,Gene/Protein	constitutive mRNA,380,397,Gene/Protein	hybrid bcr / abl,412,428,Gene/Protein	c - myc,430,437,Gene/Protein	p53,442,445,Gene/Protein	IFN - alpha,582,593,Gene/Protein	c - fos,628,635,Gene/Protein	c - myc mRNA,658,670,Gene/Protein	"[{""token"": ""c - fos transcript"", ""start_span"": 41, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""constitutive mRNA"", ""start_span"": 380, ""end_span"": 397, ""type"": ""Gene/Protein""}, {""token"": ""hybrid bcr / abl"", ""start_span"": 412, ""end_span"": 428, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 430, ""end_span"": 437, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 442, ""end_span"": 445, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 582, ""end_span"": 593, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 628, ""end_span"": 635, ""type"": ""Gene/Protein""}, {""token"": ""c - myc mRNA"", ""start_span"": 658, ""end_span"": 670, ""type"": ""Gene/Protein""}]"	valid
Sequence analysis of the 5 ' - flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF - kappa B, Egr - 1, AP - 1), which might mediate the inducible expression of this gene.	5 ' - flanking region,25,46,Gene/Protein	CD69 gene,54,63,Gene/Protein	TATA element,101,113,Gene/Protein	30 base pairs upstream,114,136,Gene/Protein	transcription initiation site,150,179,Gene/Protein	transcription factors,233,254,Gene/Protein	NF - kappa B,257,269,Gene/Protein	Egr - 1,271,278,Gene/Protein	AP - 1,280,286,Gene/Protein	"[{""token"": ""5 ' - flanking region"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""CD69 gene"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""TATA element"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""30 base pairs upstream"", ""start_span"": 114, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 150, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 233, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 280, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	valid
The exon - intron structure of the 5 ' portion of the thromboxane receptor gene was determined initially by comparing the nucleotide sequence of the 5 ' flanking genomic clone with that of a novel human uterine thromboxane receptor cDNA that extended the mRNA 141 bp further upstream than the previously identified human placental cDNA.	exon - intron structure,4,27,Gene/Protein	5 ' portion,35,46,Gene/Protein	thromboxane receptor gene,54,79,Gene/Protein	nucleotide sequence,122,141,Gene/Protein	5 ' flanking genomic clone,149,175,Gene/Protein	novel human uterine thromboxane receptor cDNA,191,236,Gene/Protein	mRNA,255,259,Gene/Protein	141 bp further upstream,260,283,Gene/Protein	previously identified human placental cDNA,293,335,Gene/Protein	"[{""token"": ""exon - intron structure"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""thromboxane receptor gene"", ""start_span"": 54, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide sequence"", ""start_span"": 122, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flanking genomic clone"", ""start_span"": 149, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""novel human uterine thromboxane receptor cDNA"", ""start_span"": 191, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""141 bp further upstream"", ""start_span"": 260, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""previously identified human placental cDNA"", ""start_span"": 293, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	valid
Appropriate sized transcripts were detected in both cultured and fresh peripheral lymphocytes for CYP11A, CYP17, HSD11L ( 11beta - hydroxysteroid dehydrogenase I), HSD17B1 ( 17beta - hydroxysteroid dehydrogenase type I) and SRD5A1 ( 5alpha - reductase I).	transcripts,18,29,Gene/Protein	CYP11A,98,104,Gene/Protein	CYP17,106,111,Gene/Protein	HSD11L,113,119,Gene/Protein	11beta - hydroxysteroid dehydrogenase I,122,161,Gene/Protein	HSD17B1,164,171,Gene/Protein	17beta - hydroxysteroid dehydrogenase type I,174,218,Gene/Protein	SRD5A1,224,230,Gene/Protein	5alpha - reductase I,233,253,Gene/Protein	"[{""token"": ""transcripts"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""CYP11A"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CYP17"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""HSD11L"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""11beta - hydroxysteroid dehydrogenase I"", ""start_span"": 122, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""HSD17B1"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""17beta - hydroxysteroid dehydrogenase type I"", ""start_span"": 174, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""SRD5A1"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""5alpha - reductase I"", ""start_span"": 233, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	test
Furthermore, EPO, but not SCF, led to activation of STAT5, whereas SCF and wortmannin had no effect on the EPO - induced STAT5 activation, suggesting that STAT5 is not involved in the synergistic action of SCF and EPO.	EPO,13,16,Gene/Protein	SCF,26,29,Gene/Protein	STAT5,52,57,Gene/Protein	SCF,67,70,Gene/Protein	EPO,107,110,Gene/Protein	STAT5,121,126,Gene/Protein	STAT5,155,160,Gene/Protein	SCF,206,209,Gene/Protein	EPO,214,217,Gene/Protein	"[{""token"": ""EPO"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	test
TPO - induced proliferation also was reduced by a specific inhibitor of the mitogen - activated protein kinase ( MAPK) pathway ( PD098059), which inhibits activation of the MAPK extracellular signal - regulated kinases ( ERK) ERK1 and ERK2, and AG490, an inhibitor of Janus kinase - 2, which completely blocked TPO - induced proliferation.	TPO,0,3,Gene/Protein	mitogen - activated protein kinase,76,110,Gene/Protein	MAPK,113,117,Gene/Protein	MAPK extracellular signal - regulated kinases,173,218,Gene/Protein	ERK,221,224,Gene/Protein	ERK1,226,230,Gene/Protein	ERK2,235,239,Gene/Protein	Janus kinase - 2,268,284,Gene/Protein	TPO,311,314,Gene/Protein	"[{""token"": ""TPO"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""MAPK extracellular signal - regulated kinases"", ""start_span"": 173, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 226, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase - 2"", ""start_span"": 268, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 311, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	test
Influenza A virus infection results in the production of chemotactic ( RANTES, MIP - 1 alpha, MCP - 1, MCP - 3, and IP - 10), pro - inflammatory ( IL - 1 beta, IL - 6, IL - 18, and TNF - alpha), and antiviral ( IFN - alpha / beta) cytokines.	RANTES,71,77,Gene/Protein	MIP - 1 alpha,79,92,Gene/Protein	MCP - 1,94,101,Gene/Protein	MCP - 3,103,110,Gene/Protein	IP - 10,116,123,Gene/Protein	IL - 1 beta,147,158,Gene/Protein	IL - 6,160,166,Gene/Protein	IL - 18,168,175,Gene/Protein	TNF - alpha,181,192,Gene/Protein	"[{""token"": ""RANTES"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1 alpha"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 3"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	test
In B6 mice, flow cytometry demonstrated an IL - 1 - dependent leukocyte infiltration into the synovial compartment and RNase protection assays revealed induction of messenger RNA ( mRNA) for the chemokines monocyte chemoattractant protein 1, macrophage inhibitory protein 2 ( MIP - 2), RANTES, MIP - 1alpha, and MIP - 1beta, in vivo and in vitro.	messenger RNA,165,178,Gene/Protein	mRNA,181,185,Gene/Protein	chemokines,195,205,Gene/Protein	monocyte chemoattractant protein 1,206,240,Gene/Protein	macrophage inhibitory protein 2,242,273,Gene/Protein	MIP - 2,276,283,Gene/Protein	RANTES,286,292,Gene/Protein	MIP - 1alpha,294,306,Gene/Protein	MIP - 1beta,312,323,Gene/Protein	"[{""token"": ""messenger RNA"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 195, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein 1"", ""start_span"": 206, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""macrophage inhibitory protein 2"", ""start_span"": 242, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 2"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 286, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 294, ""end_span"": 306, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1beta"", ""start_span"": 312, ""end_span"": 323, ""type"": ""Gene/Protein""}]"	test
IL - 13 receptor alpha chain 1 ( IL - 13R alpha 1) is necessary for binding to IL - 13, and the heterodimer composed of IL - 13R alpha 1 and IL - 4R alpha chain transduces IL - 13 and IL - 4 signals; however, the functional mapping of the intracellular domain of IL - 13R alpha 1 is not fully understood.	IL - 13 receptor alpha chain 1,0,30,Gene/Protein	IL - 13R alpha 1,33,49,Gene/Protein	IL - 13,79,86,Gene/Protein	IL - 13R alpha 1,120,136,Gene/Protein	IL - 4R alpha chain,141,160,Gene/Protein	IL - 13,172,179,Gene/Protein	IL - 4,184,190,Gene/Protein	intracellular domain,239,259,Gene/Protein	IL - 13R alpha 1,263,279,Gene/Protein	"[{""token"": ""IL - 13 receptor alpha chain 1"", ""start_span"": 0, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha 1"", ""start_span"": 33, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha 1"", ""start_span"": 120, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R alpha chain"", ""start_span"": 141, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 239, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha 1"", ""start_span"": 263, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	test
Here we report that both the acidic transcription activation domain mapping to the unique C terminus of chicken c - Rel and the F9 cell - specific activation region common to both v - Rel and c - Rel interact with the TATA - binding protein ( TBP) and transcription factor IIB ( TFIIB) in vitro and in vivo.	C terminus,90,100,Gene/Protein	chicken c - Rel,104,119,Gene/Protein	F9 cell - specific activation region,128,164,Gene/Protein	v - Rel,180,187,Gene/Protein	c - Rel,192,199,Gene/Protein	TATA - binding protein,218,240,Gene/Protein	TBP,243,246,Gene/Protein	transcription factor IIB,252,276,Gene/Protein	TFIIB,279,284,Gene/Protein	"[{""token"": ""C terminus"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""chicken c - Rel"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""F9 cell - specific activation region"", ""start_span"": 128, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""v - Rel"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""TATA - binding protein"", ""start_span"": 218, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 243, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor IIB"", ""start_span"": 252, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""TFIIB"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	test
In addition, integrin ligation leads to nuclear translocation of the p50 and p65 subunits of the NF - kappa B transcription factor, to activation of a reporter gene driven by a promoter containing NF - kappa B sites, and to increased levels of mRNAs for immediate - early genes, including the cytokine interleukin ( IL) - 1 beta.	integrin,13,21,Gene/Protein	p50,69,72,Gene/Protein	p65 subunits,77,89,Gene/Protein	NF - kappa B transcription factor,97,130,Gene/Protein	reporter gene,151,164,Gene/Protein	promoter,177,185,Gene/Protein	NF - kappa B sites,197,215,Gene/Protein	mRNAs,244,249,Gene/Protein	immediate - early genes,254,277,Gene/Protein	"[{""token"": ""integrin"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p65 subunits"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B transcription factor"", ""start_span"": 97, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B sites"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""mRNAs"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""immediate - early genes"", ""start_span"": 254, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
Kinase C mediates its effects via phosphorylation of serum response factor ( SRF) which interacts with the serum response element ( SRE); cAMP and calcium mediate their effects via phosphorylation of CREB ( cAMP regulatory element binding protein) presumably by activation of a protein kinase A or calmodulin - regulated kinase.	Kinase C,0,8,Gene/Protein	serum response factor,53,74,Gene/Protein	SRF,77,80,Gene/Protein	serum response element,107,129,Gene/Protein	SRE,132,135,Gene/Protein	CREB,200,204,Gene/Protein	cAMP regulatory element binding protein,207,246,Gene/Protein	protein kinase A,278,294,Gene/Protein	calmodulin - regulated kinase,298,327,Gene/Protein	"[{""token"": ""Kinase C"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""serum response element"", ""start_span"": 107, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""SRE"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""cAMP regulatory element binding protein"", ""start_span"": 207, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 278, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin - regulated kinase"", ""start_span"": 298, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
The interaction of the transcription factors, activator protein - 1 ( AP - 1), nuclear factor kappa B ( NF kappa B), and cAMP - responsive element binding protein ( CREB) with DNA and glucocorticoid receptors ( GR) was analyzed in human peripheral blood mononuclear cells by gel mobility shift assays.	transcription factors,23,44,Gene/Protein	activator protein - 1,46,67,Gene/Protein	AP - 1,70,76,Gene/Protein	nuclear factor kappa B,79,101,Gene/Protein	NF kappa B,104,114,Gene/Protein	cAMP - responsive element binding protein,121,162,Gene/Protein	CREB,165,169,Gene/Protein	glucocorticoid receptors,184,208,Gene/Protein	GR,211,213,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 23, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 46, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 79, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - responsive element binding protein"", ""start_span"": 121, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptors"", ""start_span"": 184, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 211, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Replacement of the NF - kappa B elements in the HIV - 1 LTR by a DNA fragment derived from the 5 ' - flanking region of IFN - stimulated gene 15 ( ISG15), containing the IFN - stimulated response element, partially restored Tat - mediated activation of LTR in T cells as well as in monocytes.	NF - kappa B elements,19,40,Gene/Protein	HIV - 1 LTR,48,59,Gene/Protein	DNA fragment,65,77,Gene/Protein	5 ' - flanking region,95,116,Gene/Protein	IFN - stimulated gene 15,120,144,Gene/Protein	ISG15,147,152,Gene/Protein	IFN - stimulated response element,170,203,Gene/Protein	Tat,224,227,Gene/Protein	LTR,253,256,Gene/Protein	"[{""token"": ""NF - kappa B elements"", ""start_span"": 19, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""DNA fragment"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - flanking region"", ""start_span"": 95, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated gene 15"", ""start_span"": 120, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""ISG15"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""IFN - stimulated response element"", ""start_span"": 170, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
The germline promoters ( Ko) located upstream of the J region gene segments of the kappa locus also contain an octamer motif ( containing a single base pair mutation and referred to as the variant octamer) which has been shown previously to bind Oct - 1 and Oct - 2 transcription factors in vitro.	germline promoters,4,22,Gene/Protein	Ko,25,27,Gene/Protein	J region gene segments,53,75,Gene/Protein	kappa locus,83,94,Gene/Protein	octamer motif,111,124,Gene/Protein	base pair mutation,147,165,Gene/Protein	Oct - 1,246,253,Gene/Protein	Oct - 2,258,265,Gene/Protein	transcription factors,266,287,Gene/Protein	"[{""token"": ""germline promoters"", ""start_span"": 4, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Ko"", ""start_span"": 25, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""J region gene segments"", ""start_span"": 53, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""kappa locus"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 111, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""base pair mutation"", ""start_span"": 147, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 258, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 266, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Although IL - 2 - induced phosphorylation of IL - 2R beta, JAK1, and STAT5 all required the presence of JAK3, IL - 4 - mediated phosphorylation of JAK1, STAT6, and insulin receptor substrates 1 and 2 did not.	IL - 2,9,15,Gene/Protein	IL - 2R beta,45,57,Gene/Protein	JAK1,59,63,Gene/Protein	STAT5,69,74,Gene/Protein	JAK3,104,108,Gene/Protein	IL - 4,110,116,Gene/Protein	JAK1,147,151,Gene/Protein	STAT6,153,158,Gene/Protein	insulin receptor,164,180,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor"", ""start_span"": 164, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Analysis of the accumulation of mRNA - encoding members of the AP - 1 transcription factor family demonstrated that c - fos and junB are also expressed upon stimulation of NK and T cells with IL - 2, but not IL - 12, whereas expression of c - jun and junD is not modified by either cytokine.	mRNA - encoding members,32,55,Gene/Protein	AP - 1 transcription factor family,63,97,Gene/Protein	c - fos,116,123,Gene/Protein	junB,128,132,Gene/Protein	IL - 2,192,198,Gene/Protein	IL - 12,208,215,Gene/Protein	c - jun,239,246,Gene/Protein	junD,251,255,Gene/Protein	cytokine,282,290,Gene/Protein	"[{""token"": ""mRNA - encoding members"", ""start_span"": 32, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 transcription factor family"", ""start_span"": 63, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""junD"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 282, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	train
Newly translated STAT1 binds in equilibrium fashion to STAT2 and STAT3, but we show that STAT2 and STAT3 exist in separate heterocomplexes with STAT1, consistent with a model in which STAT1 contains a common binding site for other STAT proteins.	STAT1,17,22,Gene/Protein	STAT2,55,60,Gene/Protein	STAT3,65,70,Gene/Protein	STAT2,89,94,Gene/Protein	STAT3,99,104,Gene/Protein	heterocomplexes,123,138,Gene/Protein	STAT1,144,149,Gene/Protein	STAT1,184,189,Gene/Protein	STAT proteins,231,244,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""heterocomplexes"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 231, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Selective phosphatase inhibitors for protein phosphatase 1 ( PP1) and 2A ( PP2A) that do not inhibit calcineurin, such as okadaic acid and calyculin A, also inhibited NFAT activation with IC50s of 87 nM and 4 nM, respectively, suggesting that okadaic acid and related inhibitors may block NFAT activation through the inhibition of PP1, instead of PP2A.	protein phosphatase 1,37,58,Gene/Protein	PP1,61,64,Gene/Protein	2A,70,72,Gene/Protein	PP2A,75,79,Gene/Protein	calcineurin,101,112,Gene/Protein	NFAT,167,171,Gene/Protein	NFAT,289,293,Gene/Protein	PP1,331,334,Gene/Protein	PP2A,347,351,Gene/Protein	"[{""token"": ""protein phosphatase 1"", ""start_span"": 37, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""2A"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 289, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 347, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	train
Pretreatment of monocytes with IFN - beta or IFN - gamma, but not IL - 1, IL - 2, macrophage colony - stimulating factor, granulocyte / macrophage colony - stimulating factor, IL - 6, or transforming growth factor beta suppressed activation of STAT6 by IL - 4.	IFN - beta,31,41,Gene/Protein	IFN - gamma,45,56,Gene/Protein	IL - 1,66,72,Gene/Protein	IL - 2,74,80,Gene/Protein	macrophage colony - stimulating factor,82,120,Gene/Protein	granulocyte / macrophage colony - stimulating factor,122,174,Gene/Protein	IL - 6,176,182,Gene/Protein	STAT6,244,249,Gene/Protein	IL - 4,253,259,Gene/Protein	"[{""token"": ""IFN - beta"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor"", ""start_span"": 82, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony - stimulating factor"", ""start_span"": 122, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
Domain E, considered as the putative hormone binding domain ( HBD) of the human mineralocorticoid receptor ( hMR) was expressed in Escherichia coli as a fusion protein with either maltose binding protein ( MBP) or glutathione S - transferase ( GST).	Domain E,0,8,Gene/Protein	putative hormone binding domain,28,59,Gene/Protein	HBD,62,65,Gene/Protein	human mineralocorticoid receptor,74,106,Gene/Protein	hMR,109,112,Gene/Protein	maltose binding protein,180,203,Gene/Protein	MBP,206,209,Gene/Protein	glutathione S - transferase,214,241,Gene/Protein	GST,244,247,Gene/Protein	"[{""token"": ""Domain E"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""putative hormone binding domain"", ""start_span"": 28, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""human mineralocorticoid receptor"", ""start_span"": 74, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""maltose binding protein"", ""start_span"": 180, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""glutathione S - transferase"", ""start_span"": 214, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""GST"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
The influence on interleukin ( IL) - 2, IL - 4 and interferon ( IFN) - gamma production; IL - 2 receptor ( IL - 2R) alpha -, beta -, and gamma - chain; and the signaling pathway molecules Janus kinase ( Jak) 1, Jak3, signal transducers and activators of transcription ( Stat) 1, Stat3, and Stat5 should be investigated.	IL - 4,40,46,Gene/Protein	beta,125,129,Gene/Protein	gamma - chain,137,150,Gene/Protein	signaling pathway molecules,160,187,Gene/Protein	Janus kinase,188,200,Gene/Protein	Jak3,211,215,Gene/Protein	activators of transcription,240,267,Gene/Protein	Stat3,279,284,Gene/Protein	Stat5,290,295,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""beta"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""gamma - chain"", ""start_span"": 137, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""signaling pathway molecules"", ""start_span"": 160, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 188, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 240, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 279, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 290, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
An electrophoretic mobility shift assay employing AP - 1 and NF - kappaB consensus oligonucleotides was used to demonstrate that AP - 1 - binding activity increased, while constitutive NF - kappaB - binding activity was not enhanced, following 2 h of CD19 cross - linking in 1E8 cells. Supershift experiments revealed that JunD and c - Fos proteins mediated anti - CD19 induced AP - 1 - binding activity in 1E8 cells.	AP - 1,50,56,Gene/Protein	NF - kappaB,61,72,Gene/Protein	AP - 1,129,135,Gene/Protein	NF - kappaB,185,196,Gene/Protein	CD19,251,255,Gene/Protein	JunD,323,327,Gene/Protein	c - Fos proteins,332,348,Gene/Protein	CD19,365,369,Gene/Protein	AP - 1,378,384,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 323, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos proteins"", ""start_span"": 332, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 365, ""end_span"": 369, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 378, ""end_span"": 384, ""type"": ""Gene/Protein""}]"	train
In the case of IgE class switching, IL - 4 activates the IgE germline promoter by inducing the interaction of the transcription factor STAT6 ( IL - 4STAT) with a responsive DNA element in the proximal region of the promoter.	IgE,15,18,Gene/Protein	IL - 4,36,42,Gene/Protein	IgE germline promoter,57,78,Gene/Protein	transcription factor,114,134,Gene/Protein	STAT6,135,140,Gene/Protein	IL - 4STAT,143,153,Gene/Protein	responsive DNA element,162,184,Gene/Protein	proximal region,192,207,Gene/Protein	promoter,215,223,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IgE germline promoter"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4STAT"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""responsive DNA element"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""proximal region"", ""start_span"": 192, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Immunological studies in human immunodeficiency virus ( HIV) - positive patients suggest that the disease progression is accompanied by a defective production of type 1 cytokines ( interleukin - 2 ( IL - 2) and IL - 12], an increased production of type 2 cytokines ( IL - 4, IL - 6, and IL - 10), and an increased production of IgE.	1 cytokines,167,178,Gene/Protein	interleukin - 2,181,196,Gene/Protein	IL - 2,199,205,Gene/Protein	IL - 12,211,218,Gene/Protein	type 2 cytokines,248,264,Gene/Protein	IL - 4,267,273,Gene/Protein	IL - 6,275,281,Gene/Protein	IL - 10,287,294,Gene/Protein	IgE,328,331,Gene/Protein	"[{""token"": ""1 cytokines"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""type 2 cytokines"", ""start_span"": 248, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 267, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 275, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 287, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
T - cell receptor ( TCR) / CD3 engagement results in the activation of nuclear factor of activated T cells ( NFAT), activator protein - 1 ( AP - 1), and nuclear factor kappaB ( NFkappaB), whereas the CD28 responsive complex ( CD28RC) is activated in response to the CD28 signal.	T - cell receptor,0,17,Gene/Protein	NFAT,109,113,Gene/Protein	activator protein - 1,116,137,Gene/Protein	AP - 1,140,146,Gene/Protein	nuclear factor kappaB,153,174,Gene/Protein	NFkappaB,177,185,Gene/Protein	CD28 responsive complex,200,223,Gene/Protein	CD28RC,226,232,Gene/Protein	CD28,266,270,Gene/Protein	"[{""token"": ""T - cell receptor"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 116, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""CD28 responsive complex"", ""start_span"": 200, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""CD28RC"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Cytokine - stimulated cell surface expression of vascular cell adhesion molecule - 1 ( VCAM - 1, CD106) and E - selectin ( ELAM - 1, CD62E), but not of intercellular adhesion molecule - 1 ( ICAM - 1, CD54), was time - and dose - dependently inhibited by TCP succinate but not by TCP or TCP acetate.	vascular cell adhesion molecule - 1,49,84,Gene/Protein	VCAM - 1,87,95,Gene/Protein	CD106,97,102,Gene/Protein	E - selectin,108,120,Gene/Protein	ELAM - 1,123,131,Gene/Protein	CD62E,133,138,Gene/Protein	intercellular adhesion molecule - 1,152,187,Gene/Protein	ICAM - 1,190,198,Gene/Protein	CD54,200,204,Gene/Protein	"[{""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 49, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CD106"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""ELAM - 1"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD62E"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 152, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD54"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Examination of the basal factors interacting with the 21 bp repeat elements through electrophoretic mobility shift ( EMS) analyses has demonstrated the formation of DNA - protein complexes common to each of the 21 bp repeats ( C1 - C3) as well as three DNA - protein complexes specific to the promoter proximal ( pp) repeat ( U1 ( U1A / U1B) and U2; 1 - 4).	basal factors,19,32,Gene/Protein	21 bp repeat elements,54,75,Gene/Protein	DNA - protein complexes,165,188,Gene/Protein	21 bp repeats,211,224,Gene/Protein	C1 - C3,227,234,Gene/Protein	DNA - protein complexes,253,276,Gene/Protein	U1,326,328,Gene/Protein	U1A / U1B,331,340,Gene/Protein	U2,346,348,Gene/Protein	"[{""token"": ""basal factors"", ""start_span"": 19, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeat elements"", ""start_span"": 54, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 165, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeats"", ""start_span"": 211, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 227, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complexes"", ""start_span"": 253, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 326, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 331, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 346, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
Putative cis - acting control elements present within a 300 - bp core promoter included two ets sites, an Sp1 site, tandem E - box domains, two GATA - associated sites ( CACCC), an AP - 2 binding site, and a GATA element at - 24.	cis - acting control elements,9,38,Gene/Protein	300 - bp core promoter,56,78,Gene/Protein	ets sites,92,101,Gene/Protein	Sp1 site,106,114,Gene/Protein	E - box domains,123,138,Gene/Protein	GATA - associated sites,144,167,Gene/Protein	AP - 2 binding site,181,200,Gene/Protein	GATA element,208,220,Gene/Protein	- 24,224,228,Gene/Protein	"[{""token"": ""cis - acting control elements"", ""start_span"": 9, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""300 - bp core promoter"", ""start_span"": 56, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""ets sites"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 site"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""E - box domains"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GATA - associated sites"", ""start_span"": 144, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 binding site"", ""start_span"": 181, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""GATA element"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""- 24"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
In order to investigate the nature of the A6H mAb costimulus at the transcriptional level we have examined induction of the transcription factors OCT - 1, AP - 1 and NF - kappa B which are known to be transcriptional regulators of several cytokine and cytokine receptor genes, including the IL - 2 and IL - 2R genes.	A6H mAb,42,49,Gene/Protein	transcription factors,124,145,Gene/Protein	OCT - 1,146,153,Gene/Protein	AP - 1,155,161,Gene/Protein	NF - kappa B,166,178,Gene/Protein	transcriptional regulators,201,227,Gene/Protein	cytokine,239,247,Gene/Protein	cytokine,252,260,Gene/Protein	IL - 2 and IL - 2R genes,291,315,Gene/Protein	"[{""token"": ""A6H mAb"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""OCT - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 201, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 239, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 and IL - 2R genes"", ""start_span"": 291, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
A motif presenting a strong similarity to an initiator was detected, as well as putative binding sites for Sp1, GATA - 2, LyF - 1, ets - 1, AP1, and MZF1 transcription factors, and two GAS motifs.	putative binding sites,80,102,Gene/Protein	Sp1,107,110,Gene/Protein	GATA - 2,112,120,Gene/Protein	LyF - 1,122,129,Gene/Protein	ets - 1,131,138,Gene/Protein	AP1,140,143,Gene/Protein	MZF1,149,153,Gene/Protein	transcription factors,154,175,Gene/Protein	GAS motifs,185,195,Gene/Protein	"[{""token"": ""putative binding sites"", ""start_span"": 80, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""LyF - 1"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ets - 1"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""MZF1"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 154, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GAS motifs"", ""start_span"": 185, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Using Tax mutants that fail to activate either ATF - or NF - kappaB - dependent promoters and different 5 ' truncation mutants of the E2F - 1 promoter, we show that the Tax - dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F - 1 promoter.	Tax,6,9,Gene/Protein	ATF,47,50,Gene/Protein	NF - kappaB - dependent promoters,56,89,Gene/Protein	5 ' truncation mutants,104,126,Gene/Protein	E2F - 1 promoter,134,150,Gene/Protein	Tax,169,172,Gene/Protein	E2F1 gene,216,225,Gene/Protein	ATF binding site,258,274,Gene/Protein	E2F - 1 promoter,290,306,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - dependent promoters"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""5 ' truncation mutants"", ""start_span"": 104, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 promoter"", ""start_span"": 134, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""E2F1 gene"", ""start_span"": 216, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""ATF binding site"", ""start_span"": 258, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""E2F - 1 promoter"", ""start_span"": 290, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
In the transient - transfection assay, ICP0, but not ICP4, activated the HIV - 1 long terminal repeat promoter region and the effect of ICP0 was greatly enhanced in the presence of the NF - kappa B binding proteins, suggesting that induction of the HIV - 1 provirus involves cooperation between the HSV - 1 - activated cellular factor, NF - kappa B, and the virus - encoded transactivator, ICP0.	ICP0,39,43,Gene/Protein	ICP4,53,57,Gene/Protein	HIV - 1 long terminal repeat promoter region,73,117,Gene/Protein	ICP0,136,140,Gene/Protein	NF - kappa B binding proteins,185,214,Gene/Protein	HSV - 1 - activated cellular factor,299,334,Gene/Protein	NF - kappa B,336,348,Gene/Protein	virus - encoded transactivator,358,388,Gene/Protein	ICP0,390,394,Gene/Protein	"[{""token"": ""ICP0"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ICP4"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat promoter region"", ""start_span"": 73, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""ICP0"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding proteins"", ""start_span"": 185, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""HSV - 1 - activated cellular factor"", ""start_span"": 299, ""end_span"": 334, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 336, ""end_span"": 348, ""type"": ""Gene/Protein""}, {""token"": ""virus - encoded transactivator"", ""start_span"": 358, ""end_span"": 388, ""type"": ""Gene/Protein""}, {""token"": ""ICP0"", ""start_span"": 390, ""end_span"": 394, ""type"": ""Gene/Protein""}]"	train
Similarly, in transfection experiments in which the selective kappa B binding sites were used to drive the expression of a chloramphenicol acetyltransferase reporter construct, the p65 - and p50 - selected motifs were activated only in the presence of p65 and p50 / 65 ( a chimeric protein with the p50 DNA binding domain and p65 activation domain) expression vectors, respectively, and neither demonstrated a significant response to stimuli that induce NF - kappa B activity.	selective kappa B binding sites,52,83,Gene/Protein	chloramphenicol acetyltransferase reporter construct,123,175,Gene/Protein	p65 - and p50 - selected motifs,181,212,Gene/Protein	p65,252,255,Gene/Protein	p50 / 65,260,268,Gene/Protein	chimeric protein,273,289,Gene/Protein	p50 DNA binding domain,299,321,Gene/Protein	p65 activation domain,326,347,Gene/Protein	NF - kappa B,454,466,Gene/Protein	"[{""token"": ""selective kappa B binding sites"", ""start_span"": 52, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter construct"", ""start_span"": 123, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""p65 - and p50 - selected motifs"", ""start_span"": 181, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""p50 / 65"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""chimeric protein"", ""start_span"": 273, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding domain"", ""start_span"": 299, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""p65 activation domain"", ""start_span"": 326, ""end_span"": 347, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 454, ""end_span"": 466, ""type"": ""Gene/Protein""}]"	train
A number of genes known to be induced following T cell activation and associated with cell growth were increased in the transfectants, including c - fos, c - myc, c - myb, HLA - DR, lck, NF - kappa B, interleukin - 2 and interleukin - 2 receptor alpha ( IL - 2R alpha).	c - fos,145,152,Gene/Protein	c - myc,154,161,Gene/Protein	c - myb,163,170,Gene/Protein	HLA - DR,172,180,Gene/Protein	lck,182,185,Gene/Protein	NF - kappa B,187,199,Gene/Protein	interleukin - 2,201,216,Gene/Protein	interleukin - 2 receptor alpha,221,251,Gene/Protein	IL - 2R alpha,254,267,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""c - myb"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""lck"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 receptor alpha"", ""start_span"": 221, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 254, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
A small 95 - bp fragment of the TCR alpha control region that contains the TCF - 1 alpha binding site juxtaposed between a cAMP - response element ( the CRE or T alpha 1 motif) and the binding site for a distinct lymphoid - specific protein ( TCF - 2 alpha) behaved as a potent T - cell - specific enhancer in vivo.	TCR alpha control region,32,56,Gene/Protein	TCF - 1 alpha binding site,75,101,Gene/Protein	cAMP - response element,123,146,Gene/Protein	CRE,153,156,Gene/Protein	T alpha 1 motif,160,175,Gene/Protein	binding site,185,197,Gene/Protein	lymphoid - specific protein,213,240,Gene/Protein	TCF - 2 alpha,243,256,Gene/Protein	T - cell - specific enhancer,278,306,Gene/Protein	"[{""token"": ""TCR alpha control region"", ""start_span"": 32, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha binding site"", ""start_span"": 75, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""cAMP - response element"", ""start_span"": 123, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""T alpha 1 motif"", ""start_span"": 160, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 185, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""lymphoid - specific protein"", ""start_span"": 213, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 2 alpha"", ""start_span"": 243, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific enhancer"", ""start_span"": 278, ""end_span"": 306, ""type"": ""Gene/Protein""}]"	train
Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL - 2 in human T cells, and specifically required a COOH - terminal region of IL - 2R beta ( Ser386 - Val525), while STAT5 recruitment was not correlated to activation of IL - 2R gamma or JAK3.	STAT5,10,15,Gene/Protein	STAT transcription factor,48,73,Gene/Protein	IL - 2,82,88,Gene/Protein	COOH - terminal region,135,157,Gene/Protein	IL - 2R beta,161,173,Gene/Protein	Ser386 - Val525,176,191,Gene/Protein	STAT5,200,205,Gene/Protein	IL - 2R gamma,254,267,Gene/Protein	JAK3,271,275,Gene/Protein	"[{""token"": ""STAT5"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""STAT transcription factor"", ""start_span"": 48, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal region"", ""start_span"": 135, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 161, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Ser386 - Val525"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 254, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Recently it has become clear that these cytokines activate a number of important intracellular signaling molecules, including the Janus kinases JAK1 and JAK3 and members of the transcription factor family of signal transducers and activators of transcription ( STATs).	cytokines,40,49,Gene/Protein	intracellular signaling molecules,81,114,Gene/Protein	Janus kinases,130,143,Gene/Protein	JAK1,144,148,Gene/Protein	JAK3,153,157,Gene/Protein	transcription factor family,177,204,Gene/Protein	signal transducers,208,226,Gene/Protein	activators of transcription,231,258,Gene/Protein	STATs,261,266,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""intracellular signaling molecules"", ""start_span"": 81, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor family"", ""start_span"": 177, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers"", ""start_span"": 208, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 231, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 261, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
However, the components of the NF - kappaB complexes were different in monocytes and B cells, because p50 is part of the NF - kappaB complex induced by CD40 triggering in both monocytes and B cells, whereas p65 was only induced in B cells. In contrast, although the Janus kinase 3 tyrosine kinase was associated with CD40 molecules in both monocytes and resting B cells, Janus kinase 3 phosphorylation induction was observed only in CD40 - activated monocytes, with subsequent induction of STAT5a DNA binding activity in the nucleus.	NF - kappaB complexes,31,52,Gene/Protein	p50,102,105,Gene/Protein	NF - kappaB complex,121,140,Gene/Protein	CD40,152,156,Gene/Protein	p65,207,210,Gene/Protein	Janus kinase 3 tyrosine kinase,266,296,Gene/Protein	CD40,317,321,Gene/Protein	Janus kinase 3,371,385,Gene/Protein	STAT5a,490,496,Gene/Protein	"[{""token"": ""NF - kappaB complexes"", ""start_span"": 31, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB complex"", ""start_span"": 121, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 207, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3 tyrosine kinase"", ""start_span"": 266, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 317, ""end_span"": 321, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 371, ""end_span"": 385, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 490, ""end_span"": 496, ""type"": ""Gene/Protein""}]"	train
Single - cell reverse transcriptase - polymerase chain reaction ( RT - PCR) analysis was applied to this culture system to investigate gene expression of diverse receptors, markers of differentiation, and transcription factors ( EKLF, GATA - 1, GATA - 2, p45 NF - E2, PU. 1, and SCL / Tal1) at discrete stages of erythropoietic development.	reverse transcriptase,14,35,Gene/Protein	receptors,162,171,Gene/Protein	markers of differentiation,173,199,Gene/Protein	transcription factors,205,226,Gene/Protein	EKLF,229,233,Gene/Protein	GATA - 1,235,243,Gene/Protein	GATA - 2,245,253,Gene/Protein	p45 NF - E2,255,266,Gene/Protein	SCL / Tal1,279,289,Gene/Protein	"[{""token"": ""reverse transcriptase"", ""start_span"": 14, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""receptors"", ""start_span"": 162, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""markers of differentiation"", ""start_span"": 173, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 205, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 245, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""p45 NF - E2"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""SCL / Tal1"", ""start_span"": 279, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
Because STAT6 activation plays an essential role in IL - 4 / IL - 13 - induced gene expression, the ability of IFN - beta and IFN - gamma to inhibit STAT6 activity provides an explanation for how IFNs can suppress IL - 4 / IL - 13 - inducible gene expression.	STAT6,8,13,Gene/Protein	IL - 4,52,58,Gene/Protein	IL - 13,61,68,Gene/Protein	IFN - beta,111,121,Gene/Protein	IFN - gamma,126,137,Gene/Protein	STAT6,149,154,Gene/Protein	IFNs,196,200,Gene/Protein	IL - 4,214,220,Gene/Protein	IL - 13,223,230,Gene/Protein	"[{""token"": ""STAT6"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""IFNs"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 214, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
The 3 ' - CAGGTG E - box could bind USF proteins, the ubiquitous repressor ZEB, or the basic helix - loop - helix proteins E2A and HEB, and we showed that a competition between ZEB and E2A / HEB proteins is involved in the silencer activity.	3 ' - CAGGTG E - box,4,24,Gene/Protein	USF proteins,36,48,Gene/Protein	ubiquitous repressor,54,74,Gene/Protein	ZEB,75,78,Gene/Protein	basic helix - loop - helix proteins,87,122,Gene/Protein	E2A,123,126,Gene/Protein	HEB,131,134,Gene/Protein	ZEB,177,180,Gene/Protein	E2A / HEB proteins,185,203,Gene/Protein	"[{""token"": ""3 ' - CAGGTG E - box"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""USF proteins"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous repressor"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""basic helix - loop - helix proteins"", ""start_span"": 87, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""HEB"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""E2A / HEB proteins"", ""start_span"": 185, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Transfection of EL - 4 cells with the IL - 4 promoter - reporter constructs carrying mutated P - like elements showed that four P - like elements, CLE0, P, P2 and P4, but not P3, were required for optimal activation of the IL - 4 promoter.	IL - 4 promoter - reporter constructs,38,75,Gene/Protein	mutated P - like elements,85,110,Gene/Protein	P - like elements,128,145,Gene/Protein	CLE0,147,151,Gene/Protein	P,153,154,Gene/Protein	P2,156,158,Gene/Protein	P4,163,165,Gene/Protein	P3,175,177,Gene/Protein	IL - 4 promoter,223,238,Gene/Protein	"[{""token"": ""IL - 4 promoter - reporter constructs"", ""start_span"": 38, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""mutated P - like elements"", ""start_span"": 85, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""P - like elements"", ""start_span"": 128, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""P"", ""start_span"": 153, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""P2"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""P4"", ""start_span"": 163, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""P3"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 promoter"", ""start_span"": 223, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	train
We show that ligand - induced homodimerization of chimeric surface receptors consisting of the extracellular and transmembrane domains of the erythropoietin receptor and of the intracellular domain of IL - 4Ralpha induces Janus kinase 1 ( Jak1) activation, STAT6 activation, and Cepsilon germline transcripts in human B cell line BJAB.	chimeric surface receptors,50,76,Gene/Protein	extracellular and transmembrane domains,95,134,Gene/Protein	erythropoietin receptor,142,165,Gene/Protein	intracellular domain,177,197,Gene/Protein	IL - 4Ralpha,201,213,Gene/Protein	Janus kinase 1,222,236,Gene/Protein	Jak1,239,243,Gene/Protein	STAT6,257,262,Gene/Protein	Cepsilon germline transcripts,279,308,Gene/Protein	"[{""token"": ""chimeric surface receptors"", ""start_span"": 50, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""extracellular and transmembrane domains"", ""start_span"": 95, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin receptor"", ""start_span"": 142, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 177, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4Ralpha"", ""start_span"": 201, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 1"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""Cepsilon germline transcripts"", ""start_span"": 279, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
Analyzed DNA sequences included delta and beta 5 ' flanking regions extending from approximately - 500 to + 50bp ( promoter regions), truncated delta and beta 5 ' flanking regions extending from approximately - 250 to + 50 bp, and chimeric promoter constructions, which consisted of a distal delta or beta fragment fused to a proximal beta or delta sequence.	DNA sequences,9,22,Gene/Protein	delta and beta 5 ' flanking regions,32,67,Gene/Protein	- 500 to + 50bp,97,112,Gene/Protein	promoter regions,115,131,Gene/Protein	beta 5 ' flanking regions,154,179,Gene/Protein	- 250 to + 50 bp,209,225,Gene/Protein	chimeric promoter constructions,231,262,Gene/Protein	delta or beta fragment,292,314,Gene/Protein	proximal beta or delta sequence,326,357,Gene/Protein	"[{""token"": ""DNA sequences"", ""start_span"": 9, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""delta and beta 5 ' flanking regions"", ""start_span"": 32, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""- 500 to + 50bp"", ""start_span"": 97, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 115, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""beta 5 ' flanking regions"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""- 250 to + 50 bp"", ""start_span"": 209, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""chimeric promoter constructions"", ""start_span"": 231, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""delta or beta fragment"", ""start_span"": 292, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""proximal beta or delta sequence"", ""start_span"": 326, ""end_span"": 357, ""type"": ""Gene/Protein""}]"	train
The PILOT protein has a calculated M ( r) of 42. 6 kDa and contains three zinc fingers of the C2H2 - type at the carboxyl - terminus which are highly homologous to the zinc finger regions of the transcription factors EGR1, EGR2, and pAT 133.	PILOT,4,9,Gene/Protein	zinc fingers,74,86,Gene/Protein	C2H2 - type,94,105,Gene/Protein	carboxyl - terminus,113,132,Gene/Protein	zinc finger regions,168,187,Gene/Protein	transcription factors,195,216,Gene/Protein	EGR1,217,221,Gene/Protein	EGR2,223,227,Gene/Protein	pAT 133,233,240,Gene/Protein	"[{""token"": ""PILOT"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""C2H2 - type"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl - terminus"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger regions"", ""start_span"": 168, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""EGR1"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""EGR2"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""pAT 133"", ""start_span"": 233, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
Results indicated that ( i) constitutive c - fos transcript levels are significantly higher in patients subsequently responding to IFN - alpha therapy ( p < 0. 01) and positively correlated with the proportion of lymphocytes ( r = 0. 6895, p < 0. 01) and negatively with the proportion of immature cells ( r = - 0. 568, p < 0. 01) contained in the pbmc preparations tested, ( ii) constitutive mRNA levels of the hybrid bcr / abl, c - myc and p53 are positively correlated with each other, but failed to relate to disease parameters, and ( iii) acute and chronic in vivo exposure to IFN - alpha is accompanied by upregulation of c - fos and downregulation of c - myc mRNA levels in responder patients.	c - fos transcript,41,59,Gene/Protein	IFN - alpha,131,142,Gene/Protein	constitutive mRNA,380,397,Gene/Protein	hybrid bcr / abl,412,428,Gene/Protein	c - myc,430,437,Gene/Protein	p53,442,445,Gene/Protein	IFN - alpha,582,593,Gene/Protein	c - fos,628,635,Gene/Protein	c - myc mRNA,658,670,Gene/Protein	"[{""token"": ""c - fos transcript"", ""start_span"": 41, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""constitutive mRNA"", ""start_span"": 380, ""end_span"": 397, ""type"": ""Gene/Protein""}, {""token"": ""hybrid bcr / abl"", ""start_span"": 412, ""end_span"": 428, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 430, ""end_span"": 437, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 442, ""end_span"": 445, ""type"": ""Gene/Protein""}, {""token"": ""IFN - alpha"", ""start_span"": 582, ""end_span"": 593, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 628, ""end_span"": 635, ""type"": ""Gene/Protein""}, {""token"": ""c - myc mRNA"", ""start_span"": 658, ""end_span"": 670, ""type"": ""Gene/Protein""}]"	train
Sequence analysis of the 5 ' - flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF - kappa B, Egr - 1, AP - 1), which might mediate the inducible expression of this gene.	5 ' - flanking region,25,46,Gene/Protein	CD69 gene,54,63,Gene/Protein	TATA element,101,113,Gene/Protein	30 base pairs upstream,114,136,Gene/Protein	transcription initiation site,150,179,Gene/Protein	transcription factors,233,254,Gene/Protein	NF - kappa B,257,269,Gene/Protein	Egr - 1,271,278,Gene/Protein	AP - 1,280,286,Gene/Protein	"[{""token"": ""5 ' - flanking region"", ""start_span"": 25, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""CD69 gene"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""TATA element"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""30 base pairs upstream"", ""start_span"": 114, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 150, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 233, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 257, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 280, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The exon - intron structure of the 5 ' portion of the thromboxane receptor gene was determined initially by comparing the nucleotide sequence of the 5 ' flanking genomic clone with that of a novel human uterine thromboxane receptor cDNA that extended the mRNA 141 bp further upstream than the previously identified human placental cDNA.	exon - intron structure,4,27,Gene/Protein	5 ' portion,35,46,Gene/Protein	thromboxane receptor gene,54,79,Gene/Protein	nucleotide sequence,122,141,Gene/Protein	5 ' flanking genomic clone,149,175,Gene/Protein	novel human uterine thromboxane receptor cDNA,191,236,Gene/Protein	mRNA,255,259,Gene/Protein	141 bp further upstream,260,283,Gene/Protein	previously identified human placental cDNA,293,335,Gene/Protein	"[{""token"": ""exon - intron structure"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""thromboxane receptor gene"", ""start_span"": 54, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide sequence"", ""start_span"": 122, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""5 ' flanking genomic clone"", ""start_span"": 149, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""novel human uterine thromboxane receptor cDNA"", ""start_span"": 191, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""141 bp further upstream"", ""start_span"": 260, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""previously identified human placental cDNA"", ""start_span"": 293, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	train
